Hannah Valantine Bridge Bio Pharma, Inc. (BBIO) insider trading activity
Hannah Valantine is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 7,465 shares of BBIO, which is worth approximately $341,673. The most recent transaction as insider was on Jun 26, 2025, when has been sold 2,418 shares (Common Stock) at a price of $44.06 per share, resulting in proceeds of $106,537. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
7.47K
323.19%
3M change
323.19%
12M change
Total Value Held
$341,673
Hannah Valantine Transaction History
Also insider at
HV
Hannah Valantine
South San Francisco, CA